Place of Origin: | Hebei,China |
---|---|
Brand Name: | Xinzhou |
Certification: | COA,GMP,CQC,SGS |
Model Number: | 131918-61-1 |
Document: | Product Brochure PDF |
Minimum Order Quantity: | 100g |
Price: | Discuss in detail |
Packaging Details: | 1kg/bag |
Delivery Time: | within 3 days |
Payment Terms: | T/T, Western Union, MoneyGram, telegraphic transfer and bitcoin |
Supply Ability: | 500kg/week |
Cas No.: | 131918-61-1 | Product Name: | Paricalcitol |
---|---|---|---|
MF: | C27H44O3 | Purity: | 99% |
Type: | API Active Pharmaceutical Ingredients/Medicine Raw Material | Grade Standard: | Medicine Grade |
Other Names: | CS-1390;PARICALCITOL(10MG)F0E3030.997MG/MG(AI);PARICALCITOL;19-nor-1alpha,25-dihydroxyvitaminD2;(1R,3R)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5S)-6-Hydroxy-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylChemicalbookidene]ethylidene]cy | Einecs No.: | 658-064-6 |
Sample: | Available | ||
Highlight: | raw active pharma ingredient,raw api active pharmaceutical ingredient |
Manufacturer Supply High Quality Paricalcitol CAS 131918-61-1 With Safe Delivery
Uses
Synthetic analog of vitamin D. Antihyperparathyroid. Antihyperparathyriod 1,25-Dihydroxy
vitamin D2 is a potent agonist of the vitamin D receptor. Paricalcitol is a synthetic 1,25-dihydroxy
vitamin D2 analog. As vitamin D deficiency, associated with chronic kidney disease, leads to an
increase in parathyroid hormone (secondary hyperparathyroidism), paricalcitol is used in renal
patients to block parathyroid hormone overproduction. Vitamin D deficiency is also a risk factor
in cancer, cardiovascular disease, hypertension, and diabetes, and paricalcitol may have
applications in those contexts as well.
Product Detail
Product name | Paricalcitol |
Cas | 131918-61-1 |
Boiling point | 564.8±50.0 °C(Predicted) |
Density | 1.121±0.06 g/cm3(Predicted) |
Flash(ing) point | 14℃ |
DMSO | 100mg/ml |
pKa | 14.34±0.40(Predicted) |
Storage | Store in a cool and dry place and keep away from direct strong light |
Shipment | EMS, DHL, UPS, Fedex etc. |
Xingtai Xinzhou Technology Co., LTD.
Xingtai Xinzhou Technology Co., Ltd. was established in 2022 with strong research and development
capabilities and superb synthesis technology, as well as advanced quality control measures. Effectively
promote the joint venture and cooperation with the major enterprises, manufacturers, with the idea of industrial
development to serve the society and the majority of users. We always adhere to the market demand as the
orientation, constantly synthesizing new high-tech chemical products and medical intermediates, mainly exported
to the United States, India, South Africa, Nigeria and other countries and regions, has a wealth of export experience,
to ensure transportation safety, can let each customer as soon as possible to safely receive the goods.